Clinical Trial Update: Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating liposomal doxorubicin plus ifosfamide for advanced or metastatic soft tissue sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• IFOSFAMIDE (IFOSFAMIDE)
• liposomal doxorubicin (doxorubicin liposomal)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Sarcoma | Phase 1 | Status: COMPLETED